Accent Microcell (NSE:ACCENTMIC) EBIT : ₹375 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Accent Microcell EBIT?

Accent Microcell's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2024 was ₹375 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹375 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Accent Microcell's annualized ROC % for the quarter that ended in Mar. 2024 was 33.42%. Accent Microcell's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 44.10%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Accent Microcell's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 9.19%.

Accent Microcell EBIT Historical Data

The historical data trend for Accent Microcell's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accent Microcell EBIT Chart

Accent Microcell Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

EBIT

89.12

103.64

169.38

375.23

Accent Microcell Semi-Annual Data
	Mar21	Mar22	Mar23	Mar24
EBIT	89.12	103.64	169.38	375.23

Competitive Comparison of Accent Microcell's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accent Microcell's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Accent Microcell's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Accent Microcell EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹375 Mil.

Accent Microcell (NSE:ACCENTMIC) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Accent Microcell's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	373.805 * ( 1 - 17.41% )	/	( (731.361	+	1116.414)	/ 2 )
=	308.7255495	/	923.8875
=	33.42 %

where

	Invested Capital		(Q: Mar. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	1106.941	-	355.082	-	( 20.498	-	max(0, 536.72	-	776.183	+	20.498	))
=	731.361

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2048.397	-	208.543	-	( 723.44	-	max(0, 378.58	-	1634.42	+	723.44	))
=	1116.414

Note: The Operating Income data used here is one times the annual (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Accent Microcell's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	375.225	/	( ( (310.17 + max(367.414, 0))	+	(399.097 + max(624.944, 0)) )	/	2 )
=	375.225	/	( ( 677.584	+	1024.041 )	/	2 )
=	375.225	/	850.8125
=	44.10 %

where Working Capital is:

	Working Capital		(Q: Mar. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(303.54	+	419.406	+	7.814)	-	(355.082	+	0	+	8.264)
=	367.414

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(538.042	+	329.832	+	22.722)	-	(208.543	+	0	+	57.109)
=	624.944

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Accent Microcell's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	375.225	/	4084.432
	=	9.19 %

Accent Microcell EBIT Related Terms

Thank you for viewing the detailed overview of Accent Microcell's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Accent Microcell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accent Microcell Ltd (NSE:ACCENTMIC) » Definitions » EBIT

Traded in Other Exchanges

N/A

Address

Shyamal Cross Roads, Anandnagar Road, 314, Shangrilla Arcade, Satellite, Ahmedabad, GJ, IND, 380015

Website

https://www.accentmicrocell.com

Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit) which generates maximum revenue, Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.

Accent Microcell Headlines

No Headlines